Stockreport

FDA allowed Athenex's IND application of Eribulin ORA to begin clinical trials [Seeking Alpha]

Athenex, Inc.  (ATNX) 
Last athenex, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.athenex.com
PDF Athenex (NASDAQ: ATNX ) announces that the FDA has allowed the IND application for it's oral version of Eribulin currently named Eribulin ORA. This FDA acti [Read more]